Williams syndrome transcription factor (WSTF) acts as an activator of estrogen receptor signaling in breast cancer cells and the effect can be abrogated by 1α,25-dihydroxyvitamin D3
Authors:
- 1 March 2018
- journal article
- conference paper
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 177, 171-178
Abstract
No abstract availableKeywords
Funding Information
- Swedish Academy of Pharmaceutical Sciences
- Magn. Bergvall’s Foundation
- Danish Cancer Society
This publication has 27 references indexed in Scilit:
- Transrepression of the estrogen receptor promoter by calcitriol in human breast cancer cells via two negative vitamin D response elementsEndocrine-Related Cancer, 2013
- 1α,25-Dihydroxyvitamin D3 exerts tissue-specific effects on estrogen and androgen metabolismBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2011
- WSTF does it all: a multifunctional protein in transcription, repair, and replicationThis paper is one of a selection of papers published in a Special Issue entitled 31st Annual International Asilomar Chromatin and Chromosomes Conference, and has undergone the Journal’s usual peer review process.Biochemistry and Cell Biology, 2011
- FulvestrantDrugs, 2011
- Tissue-Selective Regulation of Aromatase Expression by Calcitriol: Implications for Breast Cancer TherapyEndocrinology, 2010
- Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009Annals of Oncology, 2009
- Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumorsBreast Cancer Research, 2009
- Semi-quantitative scoring of potentially predictive markers for endocrine treatment of breast cancer: a comparison between whole sections and tissue microarraysJournal of Clinical Pathology, 2006
- Observer variation in immunohistochemical analysis of protein expression, time for a change?Histopathology, 2006
- Endocrine-responsive breast cancer and strategies for combating resistanceNature Reviews Cancer, 2002